Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
3T32CA009573-10S1
Application #
6340270
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Program Officer
Eckstein, David J
Project Start
1987-07-01
Project End
2001-06-30
Budget Start
1999-09-07
Budget End
2001-06-30
Support Year
10
Fiscal Year
2000
Total Cost
$45,443
Indirect Cost

  Institution

Name
Virginia Commonwealth University
Department
Surgery
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298

  Publications

Chin, Cynthia S; Miller, Catriona H T; Graham, Laura et al. (2004) Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Int Immunol 16:1283-94
Parviz, Maryam; Chin, Cynthia S; Graham, Laura J et al. (2003) Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model. Cancer Immunol Immunother 52:739-50
Chin, Cynthia S; Bear, Harry D (2002) Sentinel node mapping identifies vaccine-draining lymph nodes with tumor-specific immunological activity. Ann Surg Oncol 9:94-103
Chin, C S; Graham, L J; Hamad, G G et al. (2001) Bryostatin/ionomycin-activated T cells mediate regression of established tumors. J Surg Res 98:108-15
Lipshy, K A; Kostuchenko, P J; Hamad, G G et al. (1997) Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma. Ann Surg Oncol 4:334-41